We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Rambus Inc | NASDAQ:RMBS | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.28 | 2.20% | 59.40 | 58.84 | 59.65 | 59.85 | 57.45 | 58.03 | 1,329,199 | 01:00:00 |
Delaware
|
|
94-3112828
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
1050 Enterprise Way, Suite 700
Sunnyvale, California
|
|
|
|
94089
|
(Address of principal executive offices)
|
|
|
|
(ZIP Code)
|
|
PAGE
|
Condensed Consolidated Balance Sheets as of
March 31, 2017 and December 31, 2016
|
|
Condensed Consolidated Statements of Operations for the three
months ended March 31, 2017 and 2016
|
|
Condensed Consolidated Statements of Comprehensive
Income for the three months ended March 31, 2017 and 2016
|
|
Condensed Consolidated Statements of Cash Flows for the
three months ended March 31, 2017 and 2016
|
|
•
|
Success in the markets of our products and services or our customers’ products;
|
•
|
Sources of competition;
|
•
|
Research and development costs and improvements in technology;
|
•
|
Sources, amounts and concentration of revenue, including royalties;
|
•
|
Success in signing and renewing license agreements;
|
•
|
Terms of our licenses and amounts owed under license agreements;
|
•
|
Technology product development;
|
•
|
Dispositions, acquisitions, mergers or strategic transactions and our related integration efforts, including our acquisitions of Smart Card Software Ltd., the assets of Semtech Corporation's Snowbush IP group and Inphi Corporation's Memory Interconnect Business;
|
•
|
Impairment of goodwill and long-lived assets;
|
•
|
Pricing policies of our customers;
|
•
|
Changes in our strategy and business model, including the expansion of our portfolio of inventions, products, software, services and solutions to address additional markets in lighting, memory, chip, mobile payments, smart ticketing and security;
|
•
|
Deterioration of financial health of commercial counterparties and their ability to meet their obligations to us;
|
•
|
Effects of security breaches or failures in our or our customers’ products and services on our business;
|
•
|
Engineering, sales and general and administration expenses;
|
•
|
Contract revenue;
|
•
|
Operating results;
|
•
|
International licenses, operations and expansion;
|
•
|
Effects of changes in the economy and credit market on our industry and business;
|
•
|
Ability to identify, attract, motivate and retain qualified personnel;
|
•
|
Effects of government regulations on our industry and business;
|
•
|
Manufacturing, shipping and supply partners and/or sale and distribution channels;
|
•
|
Growth in our business;
|
•
|
Methods, estimates and judgments in accounting policies;
|
•
|
Adoption of new accounting pronouncements;
|
•
|
Effective tax rates;
|
•
|
Restructurings and plans of termination;
|
•
|
Realization of deferred tax assets/release of deferred tax valuation allowance;
|
•
|
Trading price of our common stock;
|
•
|
Internal control environment;
|
•
|
The level and terms of our outstanding debt and the repayment or financing of such debt;
|
•
|
Protection of intellectual property;
|
•
|
Any changes in laws, agency actions and judicial rulings that may impact the ability to enforce intellectual property rights;
|
•
|
Indemnification and technical support obligations;
|
•
|
Equity repurchase plans;
|
•
|
Issuances of debt or equity securities, which could involve restrictive covenants or be dilutive to our existing stockholders;
|
•
|
Effects of fluctuations in currency exchange rates;
|
•
|
Outcome and effect of potential future intellectual property litigation and other significant litigation; and
|
•
|
Likelihood of paying dividends.
|
|
March 31,
2017 |
|
December 31,
2016 |
||||
|
(In thousands, except shares
and par value)
|
||||||
ASSETS
|
|
|
|
|
|
||
Current assets:
|
|
|
|
|
|
||
Cash and cash equivalents
|
$
|
177,455
|
|
|
$
|
135,294
|
|
Marketable securities
|
10,170
|
|
|
36,888
|
|
||
Accounts receivable
|
27,353
|
|
|
21,099
|
|
||
Prepaids and other current assets
|
12,676
|
|
|
17,867
|
|
||
Inventories
|
5,840
|
|
|
5,633
|
|
||
Total current assets
|
233,494
|
|
|
216,781
|
|
||
Intangible assets, net
|
121,355
|
|
|
132,388
|
|
||
Goodwill
|
206,085
|
|
|
204,794
|
|
||
Property, plant and equipment, net
|
56,468
|
|
|
58,442
|
|
||
Deferred tax assets
|
206,075
|
|
|
168,342
|
|
||
Other assets
|
2,733
|
|
|
2,749
|
|
||
Total assets
|
$
|
826,210
|
|
|
$
|
783,496
|
|
LIABILITIES &
STOCKHOLDERS’ EQUITY
|
|
|
|
|
|
||
Current liabilities:
|
|
|
|
|
|
||
Accounts payable
|
$
|
8,437
|
|
|
$
|
9,793
|
|
Accrued salaries and benefits
|
10,576
|
|
|
14,177
|
|
||
Deferred revenue
|
15,658
|
|
|
16,932
|
|
||
Other current liabilities
|
9,453
|
|
|
10,399
|
|
||
Total current liabilities
|
44,124
|
|
|
51,301
|
|
||
Convertible notes, long-term
|
127,916
|
|
|
126,167
|
|
||
Long-term imputed financing obligation
|
37,859
|
|
|
38,029
|
|
||
Other long-term liabilities
|
14,754
|
|
|
15,217
|
|
||
Total liabilities
|
224,653
|
|
|
230,714
|
|
||
Commitments and contingencies (Notes 9 and 13)
|
|
|
|
|
|
||
Stockholders’ equity:
|
|
|
|
|
|
||
Convertible preferred stock, $.001 par value:
|
|
|
|
|
|
||
Authorized: 5,000,000 shares
|
|
|
|
|
|
||
Issued and outstanding: no shares at March 31, 2017 and December 31, 2016
|
—
|
|
|
—
|
|
||
Common stock, $.001 par value:
|
|
|
|
|
|
||
Authorized: 500,000,000 shares
|
|
|
|
|
|
||
Issued and outstanding: 111,729,448 shares at March 31, 2017 and 111,053,734 shares at December 31, 2016
|
112
|
|
|
111
|
|
||
Additional paid-in capital
|
1,187,515
|
|
|
1,181,230
|
|
||
Accumulated deficit
|
(573,802
|
)
|
|
(615,051
|
)
|
||
Accumulated other comprehensive loss
|
(12,268
|
)
|
|
(13,508
|
)
|
||
Total stockholders’ equity
|
601,557
|
|
|
552,782
|
|
||
Total liabilities and stockholders’ equity
|
$
|
826,210
|
|
|
$
|
783,496
|
|
|
Three Months Ended
|
||||||
|
March 31,
|
||||||
|
2017
|
|
2016
|
||||
|
(In thousands, except per share amounts)
|
||||||
Revenue:
|
|
|
|
|
|
||
Royalties
|
$
|
68,956
|
|
|
$
|
62,877
|
|
Contract and other revenue
|
28,395
|
|
|
9,805
|
|
||
Total revenue
|
97,351
|
|
|
72,682
|
|
||
Operating costs and expenses:
|
|
|
|
|
|
||
Cost of revenue*
|
19,731
|
|
|
12,207
|
|
||
Research and development*
|
36,000
|
|
|
28,527
|
|
||
Sales, general and administrative*
|
28,186
|
|
|
23,095
|
|
||
Gain from settlement
|
—
|
|
|
(441
|
)
|
||
Total operating costs and expenses
|
83,917
|
|
|
63,388
|
|
||
Operating income
|
13,434
|
|
|
9,294
|
|
||
Interest income and other income (expense), net
|
154
|
|
|
242
|
|
||
Interest expense
|
(3,206
|
)
|
|
(3,141
|
)
|
||
Interest and other income (expense), net
|
(3,052
|
)
|
|
(2,899
|
)
|
||
Income before income taxes
|
10,382
|
|
|
6,395
|
|
||
Provision for income taxes
|
7,376
|
|
|
4,517
|
|
||
Net income
|
$
|
3,006
|
|
|
$
|
1,878
|
|
Net income per share:
|
|
|
|
|
|
||
Basic
|
$
|
0.03
|
|
|
$
|
0.02
|
|
Diluted
|
$
|
0.03
|
|
|
$
|
0.02
|
|
Weighted average shares used in per share calculation:
|
|
|
|
|
|
||
Basic
|
111,464
|
|
|
109,733
|
|
||
Diluted
|
115,325
|
|
|
112,252
|
|
Cost of revenue
|
$
|
14
|
|
|
$
|
14
|
|
Research and development
|
$
|
3,012
|
|
|
$
|
2,080
|
|
Sales, general and administrative
|
$
|
3,570
|
|
|
$
|
2,770
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31,
|
||||||
(In thousands)
|
|
2017
|
|
2016
|
||||
Net income
|
|
$
|
3,006
|
|
|
$
|
1,878
|
|
Other comprehensive income (loss):
|
|
|
|
|
|
|
||
Foreign currency translation adjustment
|
|
999
|
|
|
(640
|
)
|
||
Unrealized gain (loss) on marketable securities, net of tax
|
|
240
|
|
|
(183
|
)
|
||
Total comprehensive income
|
|
$
|
4,245
|
|
|
$
|
1,055
|
|
|
Three Months Ended
|
||||||
|
March 31,
|
||||||
|
2017
|
|
2016
|
||||
|
(In thousands)
|
||||||
Cash flows from operating activities:
|
|
|
|
|
|
||
Net income
|
$
|
3,006
|
|
|
$
|
1,878
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
|
|
||
Stock-based compensation
|
6,596
|
|
|
4,864
|
|
||
Depreciation
|
3,392
|
|
|
2,969
|
|
||
Amortization of intangible assets
|
10,488
|
|
|
7,719
|
|
||
Non-cash interest expense and amortization of convertible debt issuance costs
|
1,749
|
|
|
1,651
|
|
||
Deferred income taxes
|
(214
|
)
|
|
1,142
|
|
||
Excess tax benefits from stock-based compensation
|
—
|
|
|
(485
|
)
|
||
Gain from sale of property, plant and equipment
|
(13
|
)
|
|
(37
|
)
|
||
Change in operating assets and liabilities, net of impact of acquisitions:
|
|
|
|
|
|
||
Accounts receivable
|
(5,484
|
)
|
|
10,015
|
|
||
Prepaid expenses and other assets
|
4,665
|
|
|
(1,560
|
)
|
||
Inventories
|
(208
|
)
|
|
(838
|
)
|
||
Accounts payable
|
(978
|
)
|
|
266
|
|
||
Accrued salaries and benefits and other liabilities
|
(4,702
|
)
|
|
(8,566
|
)
|
||
Deferred revenue
|
(1,120
|
)
|
|
(1,236
|
)
|
||
Net cash provided by operating activities
|
17,177
|
|
|
17,782
|
|
||
Cash flows from investing activities:
|
|
|
|
|
|
||
Purchases of property, plant and equipment
|
(1,918
|
)
|
|
(1,599
|
)
|
||
Maturities of marketable securities
|
27,048
|
|
|
54,585
|
|
||
Proceeds from sale of property, plant and equipment
|
17
|
|
|
—
|
|
||
Acquisitions of businesses, net of cash acquired
|
—
|
|
|
(80,523
|
)
|
||
Net cash provided by (used in) investing activities
|
25,147
|
|
|
(27,537
|
)
|
||
Cash flows from financing activities:
|
|
|
|
||||
Proceeds received from issuance of common stock under employee stock plans
|
2,247
|
|
|
3,799
|
|
||
Principal payments against lease financing obligation
|
(190
|
)
|
|
(140
|
)
|
||
Payments of taxes on restricted stock units
|
(2,593
|
)
|
|
(1,482
|
)
|
||
Excess tax benefits from stock-based compensation
|
—
|
|
|
485
|
|
||
Net cash provided by (used in) financing activities
|
(536
|
)
|
|
2,662
|
|
||
Effect of exchange rate changes on cash and cash equivalents
|
373
|
|
|
(42
|
)
|
||
Net increase (decrease) in cash and cash equivalents
|
42,161
|
|
|
(7,135
|
)
|
||
Cash and cash equivalents at beginning of period
|
135,294
|
|
|
143,764
|
|
||
Cash and cash equivalents at end of period
|
$
|
177,455
|
|
|
$
|
136,629
|
|
|
|
|
|
||||
Non-cash investing activities during the period:
|
|
|
|
|
|
||
Property, plant and equipment received and accrued in accounts payable and other liabilities
|
$
|
152
|
|
|
$
|
830
|
|
Non-cash financing activities during the period:
|
|
|
|
||||
Additional purchase consideration from acquisition
|
$
|
—
|
|
|
$
|
12,100
|
|
|
Three Months Ended March 31,
|
||||||
|
2017
|
|
2016
|
||||
Net income per share:
|
(In thousands, except per share amounts)
|
||||||
Numerator:
|
|
|
|
|
|
||
Net income
|
$
|
3,006
|
|
|
$
|
1,878
|
|
Denominator:
|
|
|
|
||||
Weighted-average shares outstanding - basic
|
111,464
|
|
|
109,733
|
|
||
Effect of potential dilutive common shares
|
3,861
|
|
|
2,519
|
|
||
Weighted-average shares outstanding - diluted
|
115,325
|
|
|
112,252
|
|
||
Basic net income per share
|
$
|
0.03
|
|
|
$
|
0.02
|
|
Diluted net income per share
|
$
|
0.03
|
|
|
$
|
0.02
|
|
Reportable Segment:
|
|
As of December 31, 2016
|
|
Additions to Goodwill (1)
|
|
Impairment Charge of Goodwill
|
|
Effect of Exchange Rates (2)
|
|
As of March 31, 2017
|
||||||||||
|
|
(In thousands)
|
||||||||||||||||||
MID
|
|
$
|
66,643
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
66,643
|
|
RSD
|
|
138,151
|
|
|
803
|
|
|
—
|
|
|
488
|
|
|
139,442
|
|
|||||
Total
|
|
$
|
204,794
|
|
|
$
|
803
|
|
|
$
|
—
|
|
|
$
|
488
|
|
|
$
|
206,085
|
|
|
|
As of
|
||||||||||
|
|
March 31, 2017
|
||||||||||
Reportable Segment:
|
|
Gross Carrying Amount
|
|
Accumulated Impairment Losses
|
|
Net Carrying Amount
|
||||||
|
|
(In thousands)
|
||||||||||
MID
|
|
$
|
66,643
|
|
|
$
|
—
|
|
|
$
|
66,643
|
|
RSD
|
|
139,442
|
|
|
—
|
|
|
139,442
|
|
|||
Other
|
|
21,770
|
|
|
(21,770
|
)
|
|
—
|
|
|||
Total
|
|
$
|
227,855
|
|
|
$
|
(21,770
|
)
|
|
$
|
206,085
|
|
|
|
|
As of March 31, 2017
|
||||||||||
|
Useful Life
|
|
Gross Carrying
Amount (1)
|
|
Accumulated
Amortization
|
|
Net Carrying
Amount
|
||||||
|
|
|
(In thousands)
|
||||||||||
Existing technology
|
3 to 10 years
|
|
$
|
256,929
|
|
|
$
|
(165,479
|
)
|
|
$
|
91,450
|
|
Customer contracts and contractual relationships
|
1 to 10 years
|
|
65,595
|
|
|
(40,790
|
)
|
|
24,805
|
|
|||
Non-compete agreements and trademarks
|
3 years
|
|
300
|
|
|
(300
|
)
|
|
—
|
|
|||
In-process research and development
|
Not applicable
|
|
5,100
|
|
|
—
|
|
|
5,100
|
|
|||
Total intangible assets
|
|
|
$
|
327,924
|
|
|
$
|
(206,569
|
)
|
|
$
|
121,355
|
|
|
|
|
As of December 31, 2016
|
||||||||||
|
Useful Life
|
|
Gross Carrying
Amount
|
|
Accumulated
Amortization
|
|
Net Carrying
Amount
|
||||||
|
|
|
(In thousands)
|
||||||||||
Existing technology
|
3 to 10 years
|
|
$
|
256,656
|
|
|
$
|
(156,577
|
)
|
|
$
|
100,079
|
|
Customer contracts and contractual relationships
|
1 to 10 years
|
|
65,109
|
|
|
(37,900
|
)
|
|
27,209
|
|
|||
Non-compete agreements and trademarks
|
3 years
|
|
300
|
|
|
(300
|
)
|
|
—
|
|
|||
In-process research and development
|
Not applicable
|
|
5,100
|
|
|
—
|
|
|
5,100
|
|
|||
Total intangible assets
|
|
|
$
|
327,165
|
|
|
$
|
(194,777
|
)
|
|
$
|
132,388
|
|
Years Ending December 31:
|
Amount
|
||
2017 (remaining 9 months)
|
$
|
33,021
|
|
2018
|
28,976
|
|
|
2019
|
19,239
|
|
|
2020
|
18,560
|
|
|
2021
|
12,298
|
|
|
Thereafter
|
9,261
|
|
|
|
$
|
121,355
|
|
|
For the Three Months Ended March 31, 2017
|
||||||||||||||
|
MID
|
|
RSD
|
|
Other
|
|
Total
|
||||||||
|
(In thousands)
|
||||||||||||||
Revenues
|
$
|
70,595
|
|
|
$
|
23,205
|
|
|
$
|
3,551
|
|
|
$
|
97,351
|
|
Segment operating expenses
|
20,255
|
|
|
12,399
|
|
|
8,735
|
|
|
41,389
|
|
||||
Segment operating income (loss)
|
$
|
50,340
|
|
|
$
|
10,806
|
|
|
$
|
(5,184
|
)
|
|
$
|
55,962
|
|
Reconciling items
|
|
|
|
|
|
|
|
|
(42,528
|
)
|
|||||
Operating income
|
|
|
|
|
|
|
|
|
$
|
13,434
|
|
||||
Interest and other income (expense), net
|
|
|
|
|
|
|
|
|
(3,052
|
)
|
|||||
Income before income taxes
|
|
|
|
|
|
|
|
|
$
|
10,382
|
|
|
For the Three Months Ended March 31, 2016
|
||||||||||||||
|
MID
|
|
RSD
|
|
Other
|
|
Total
|
||||||||
|
(In thousands)
|
||||||||||||||
Revenues
|
$
|
53,545
|
|
|
$
|
14,101
|
|
|
$
|
5,036
|
|
|
$
|
72,682
|
|
Segment operating expenses
|
12,043
|
|
|
11,910
|
|
|
7,126
|
|
|
31,079
|
|
||||
Segment operating income (loss)
|
$
|
41,502
|
|
|
$
|
2,191
|
|
|
$
|
(2,090
|
)
|
|
$
|
41,603
|
|
Reconciling items
|
|
|
|
|
|
|
|
|
(32,309
|
)
|
|||||
Operating income
|
|
|
|
|
|
|
|
|
$
|
9,294
|
|
||||
Interest and other income (expense), net
|
|
|
|
|
|
|
|
|
(2,899
|
)
|
|||||
Income before income taxes
|
|
|
|
|
|
|
|
|
$
|
6,395
|
|
|
|
As of
|
||||
Customer
|
|
March 31, 2017
|
|
December 31, 2016
|
||
Customer 1 (RSD reportable segment)
|
|
*
|
|
|
17
|
%
|
Customer 2 (Other segment)
|
|
10
|
%
|
|
12
|
%
|
Customer 3 (MID reportable segment)
|
|
14
|
%
|
|
13
|
%
|
|
|
Three Months Ended
|
||||
|
|
March 31,
|
||||
Customer
|
|
2017
|
|
2016
|
||
Customer A (MID and RSD reportable segments)
|
|
17
|
%
|
|
21
|
%
|
Customer B (MID reportable segment)
|
|
13
|
%
|
|
22
|
%
|
Customer C (MID reportable segment)
|
|
14
|
%
|
|
13
|
%
|
|
|
As of March 31, 2017
|
|||||||||||||||||
(In thousands)
|
|
Fair Value
|
|
Amortized
Cost
|
|
Gross
Unrealized
Gains
|
|
Gross
Unrealized
Losses
|
|
Weighted
Rate of
Return
|
|||||||||
Money market funds
|
|
$
|
11,075
|
|
|
$
|
11,075
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
0.60
|
%
|
U.S. Government bonds and notes
|
|
35,975
|
|
|
35,975
|
|
|
1
|
|
|
(1
|
)
|
|
0.72
|
%
|
||||
Corporate notes, bonds, commercial paper and other
|
|
86,647
|
|
|
86,669
|
|
|
—
|
|
|
(22
|
)
|
|
0.80
|
%
|
||||
Total cash equivalents and marketable securities
|
|
133,697
|
|
|
133,719
|
|
|
1
|
|
|
(23
|
)
|
|
|
|
||||
Cash
|
|
53,928
|
|
|
53,928
|
|
|
—
|
|
|
—
|
|
|
|
|
||||
Total cash, cash equivalents and marketable securities
|
|
$
|
187,625
|
|
|
$
|
187,647
|
|
|
$
|
1
|
|
|
$
|
(23
|
)
|
|
|
|
|
|
As of December 31, 2016
|
|||||||||||||||||
(In thousands)
|
|
Fair Value
|
|
Amortized
Cost
|
|
Gross
Unrealized
Gains
|
|
Gross
Unrealized
Losses
|
|
Weighted
Rate of
Return
|
|||||||||
Money market funds
|
|
$
|
10,681
|
|
|
$
|
10,681
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
0.41
|
%
|
U.S. Government bonds and notes
|
|
48,292
|
|
|
48,291
|
|
|
1
|
|
|
—
|
|
|
0.39
|
%
|
||||
Corporate notes, bonds, commercial paper and other
|
|
62,178
|
|
|
62,199
|
|
|
—
|
|
|
(21
|
)
|
|
0.66
|
%
|
||||
Total cash equivalents and marketable securities
|
|
121,151
|
|
|
121,171
|
|
|
1
|
|
|
(21
|
)
|
|
|
|
||||
Cash
|
|
51,031
|
|
|
51,031
|
|
|
—
|
|
|
—
|
|
|
|
|
||||
Total cash, cash equivalents and marketable securities
|
|
$
|
172,182
|
|
|
$
|
172,202
|
|
|
$
|
1
|
|
|
$
|
(21
|
)
|
|
|
|
|
As of
|
||||||
|
March 31,
2017 |
|
December 31,
2016 |
||||
|
(In thousands)
|
||||||
Cash equivalents
|
$
|
123,527
|
|
|
$
|
84,263
|
|
Short term marketable securities
|
10,170
|
|
|
36,888
|
|
||
Total cash equivalents and marketable securities
|
133,697
|
|
|
121,151
|
|
||
Cash
|
53,928
|
|
|
51,031
|
|
||
Total cash, cash equivalents and marketable securities
|
$
|
187,625
|
|
|
$
|
172,182
|
|
|
Fair Value
|
|
Gross Unrealized Loss
|
||||||||||||
|
March 31,
2017 |
|
December 31,
2016 |
|
March 31,
2017 |
|
December 31,
2016 |
||||||||
|
(In thousands)
|
||||||||||||||
Less than one year
|
|
|
|
|
|
|
|
|
|
|
|
||||
U.S. Government bonds and notes
|
$
|
12,982
|
|
|
$
|
18,395
|
|
|
$
|
(1
|
)
|
|
$
|
—
|
|
Corporate notes, bonds and commercial paper
|
85,967
|
|
|
54,377
|
|
|
(22
|
)
|
|
(21
|
)
|
||||
Total Corporate notes, bonds, and commercial paper and U.S. Government bonds and notes
|
$
|
98,949
|
|
|
$
|
72,772
|
|
|
$
|
(23
|
)
|
|
$
|
(21
|
)
|
|
As of March 31, 2017
|
||||||||||||||
|
Total
|
|
Quoted
Market
Prices in
Active
Markets
(Level 1)
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||
|
(In thousands)
|
||||||||||||||
Money market funds
|
$
|
11,075
|
|
|
$
|
11,075
|
|
|
$
|
—
|
|
|
$
|
—
|
|
U.S. Government bonds and notes
|
35,975
|
|
|
—
|
|
|
35,975
|
|
|
—
|
|
||||
Corporate notes, bonds, commercial paper and other
|
86,647
|
|
|
680
|
|
|
85,967
|
|
|
—
|
|
||||
Total available-for-sale securities
|
$
|
133,697
|
|
|
$
|
11,755
|
|
|
$
|
121,942
|
|
|
$
|
—
|
|
|
As of December 31, 2016
|
||||||||||||||
|
Total
|
|
Quoted
Market
Prices in
Active
Markets
(Level 1)
|
|
Significant
Other
Observable
Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||
|
(In thousands)
|
||||||||||||||
Money market funds
|
$
|
10,681
|
|
|
$
|
10,681
|
|
|
$
|
—
|
|
|
$
|
—
|
|
U.S. Government bonds and notes
|
48,292
|
|
|
—
|
|
|
48,292
|
|
|
—
|
|
||||
Corporate notes, bonds, commercial paper and other
|
62,178
|
|
|
303
|
|
|
61,875
|
|
|
—
|
|
||||
Total available-for-sale securities
|
$
|
121,151
|
|
|
$
|
10,984
|
|
|
$
|
110,167
|
|
|
$
|
—
|
|
|
|
As of March 31, 2017
|
|
As of December 31, 2016
|
||||||||||||||||||||
(In thousands)
|
|
Face
Value
|
|
Carrying
Value
|
|
Fair Value
|
|
Face
Value
|
|
Carrying
Value
|
|
Fair Value
|
||||||||||||
1.125% Convertible Senior Notes due 2018 (the "2018 Notes")
|
|
$
|
138,000
|
|
|
$
|
127,916
|
|
|
$
|
162,669
|
|
|
$
|
138,000
|
|
|
$
|
126,167
|
|
|
$
|
173,961
|
|
(In thousands)
|
|
As of March 31, 2017
|
|
As of December 31, 2016
|
||||
1.125% Convertible Senior Notes due 2018
|
|
$
|
138,000
|
|
|
$
|
138,000
|
|
Unamortized discount
|
|
(9,305
|
)
|
|
(10,913
|
)
|
||
Unamortized debt issuance costs
|
|
(779
|
)
|
|
(920
|
)
|
||
Total convertible notes
|
|
$
|
127,916
|
|
|
$
|
126,167
|
|
Less current portion
|
|
—
|
|
|
—
|
|
||
Total long-term convertible notes
|
|
$
|
127,916
|
|
|
$
|
126,167
|
|
|
Three Months Ended
|
||||||
|
March 31,
|
||||||
|
2017
|
|
2016
|
||||
|
(In thousands)
|
||||||
2018 Notes coupon interest at a rate of 1.125%
|
$
|
388
|
|
|
$
|
388
|
|
2018 Notes amortization of discount and debt issuance costs at an additional effective interest rate of 5.5%
|
1,749
|
|
|
1,651
|
|
||
Total interest expense on convertible notes
|
$
|
2,137
|
|
|
$
|
2,039
|
|
|
Total
|
|
Remainder
of 2017
|
|
2018
|
|
2019
|
|
2020
|
|
2021
|
|
Thereafter
|
||||||||||||||
Contractual obligations (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Imputed financing obligation (2)
|
$
|
20,661
|
|
|
$
|
4,743
|
|
|
$
|
6,447
|
|
|
$
|
6,602
|
|
|
$
|
2,869
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Leases and other contractual obligations
|
13,947
|
|
|
5,086
|
|
|
3,400
|
|
|
2,194
|
|
|
1,353
|
|
|
1,369
|
|
|
545
|
|
|||||||
Software licenses (3)
|
21,009
|
|
|
7,251
|
|
|
10,226
|
|
|
3,532
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||
Convertible notes
|
138,000
|
|
|
—
|
|
|
138,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||
Interest payments related to convertible notes
|
2,328
|
|
|
776
|
|
|
1,552
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||
Total
|
$
|
195,945
|
|
|
$
|
17,856
|
|
|
$
|
159,625
|
|
|
$
|
12,328
|
|
|
$
|
4,222
|
|
|
$
|
1,369
|
|
|
$
|
545
|
|
(1)
|
The above table does not reflect possible payments in connection with uncertain tax benefits of approximately
$23.1 million
including
$20.7 million
recorded as a reduction of long-term deferred tax assets and
$2.4 million
in long-term income taxes payable as of
March 31, 2017
. As noted below in Note 12, “Income Taxes,” although it is possible that some of the unrecognized tax benefits could be settled within the next 12 months, the Company cannot reasonably estimate the outcome at this time.
|
(2)
|
With respect to the imputed financing obligation, the main components of the difference between the amount reflected in the contractual obligations table and the amount reflected on the unaudited condensed consolidated balance sheets are the interest on the imputed financing obligation and the estimated common area expenses over the future periods. The amount includes the amended Ohio lease and the amended Sunnyvale lease.
|
(3)
|
The Company has commitments with various software vendors for non-cancellable agreements generally having terms longer than
one
year.
|
|
Shares Available
for Grant
|
|
Shares available as of December 31, 2016
|
7,305,368
|
|
Stock options granted
|
(458,426
|
)
|
Stock options forfeited
|
860,206
|
|
Nonvested equity stock and stock units granted (1) (2)
|
(3,326,559
|
)
|
Nonvested equity stock and stock units forfeited (1)
|
372,780
|
|
Total available for grant as of March 31, 2017
|
4,753,369
|
|
(1)
|
For purposes of determining the number of shares available for grant under the 2015 Plan against the maximum number of shares authorized, each share of restricted stock granted reduces the number of shares available for grant by
1.5
shares and each share of restricted stock forfeited increases shares available for grant by
1.5
shares.
|
(2)
|
Amount includes
266,847
shares that have been reserved for potential future issuance related to certain performance unit awards granted in the first quarter of 2017 and discussed under the section titled "Nonvested Equity Stock and Stock Units" below.
|
|
Options Outstanding
|
|
|
|
|
|||||||
|
Number of
Shares
|
|
Weighted
Average
Exercise Price
Per Share
|
|
Weighted
Average
Remaining
Contractual
Term (years)
|
|
Aggregate
Intrinsic
Value
|
|||||
|
(In thousands, except per share amounts)
|
|||||||||||
Outstanding as of December 31, 2016
|
7,008,833
|
|
|
$
|
9.34
|
|
|
|
|
|
|
|
Options granted
|
458,426
|
|
|
$
|
12.80
|
|
|
|
|
|
|
|
Options exercised
|
(324,985
|
)
|
|
$
|
7.03
|
|
|
|
|
|
|
|
Options forfeited
|
(860,206
|
)
|
|
$
|
14.55
|
|
|
|
|
|
|
|
Outstanding as of March 31, 2017
|
6,282,068
|
|
|
$
|
9.00
|
|
|
5.49
|
|
$
|
29,538
|
|
Vested or expected to vest at March 31, 2017
|
6,175,245
|
|
|
$
|
8.96
|
|
|
5.44
|
|
$
|
29,335
|
|
Options exercisable at March 31, 2017
|
4,060,026
|
|
|
$
|
8.99
|
|
|
4.55
|
|
$
|
20,333
|
|
|
Stock Option Plan
|
||||||
|
Three Months Ended
|
||||||
|
March 31,
|
||||||
|
2017
|
|
2016
|
||||
Stock Option Plan
|
|
|
|
|
|
||
Expected stock price volatility
|
32
|
%
|
|
36
|
%
|
||
Risk free interest rate
|
1.9
|
%
|
|
1.7
|
%
|
||
Expected term (in years)
|
5.4
|
|
|
6.1
|
|
||
Weighted-average fair value of stock options granted to employees
|
$
|
4.14
|
|
|
$
|
4.66
|
|
|
|
|
|
Nonvested Equity Stock and Stock Units
|
|
Shares
|
|
Weighted-
Average
Grant-Date
Fair Value
|
|||
Nonvested at December 31, 2016
|
|
4,863,056
|
|
|
$
|
12.33
|
|
Granted
|
|
2,039,808
|
|
|
$
|
12.82
|
|
Vested
|
|
(553,505
|
)
|
|
$
|
11.47
|
|
Forfeited
|
|
(222,609
|
)
|
|
$
|
12.24
|
|
Nonvested at March 31, 2017
|
|
6,126,750
|
|
|
$
|
12.57
|
|
•
|
Revenue of $97.4 million;
|
•
|
Total Operating Costs and Expenses of $83.9 million;
|
•
|
Diluted net income per share of $0.03; and
|
•
|
Operating cash flows of $17.2 million
|
|
Three Months Ended
|
||||
|
March 31,
|
||||
|
2017
|
|
2016
|
||
Revenue:
|
|
|
|
|
|
Royalties
|
70.8
|
%
|
|
86.5
|
%
|
Contract and other revenue
|
29.2
|
%
|
|
13.5
|
%
|
Total revenue
|
100.0
|
%
|
|
100.0
|
%
|
Operating costs and expenses:
|
|
|
|
|
|
Cost of revenue*
|
20.3
|
%
|
|
16.8
|
%
|
Research and development*
|
37.0
|
%
|
|
39.2
|
%
|
Sales, general and administrative*
|
28.9
|
%
|
|
31.8
|
%
|
Gain from settlement
|
—
|
%
|
|
(0.6
|
)%
|
Total operating costs and expenses
|
86.2
|
%
|
|
87.2
|
%
|
Operating income
|
13.8
|
%
|
|
12.8
|
%
|
Interest income and other income (expense), net
|
0.2
|
%
|
|
0.3
|
%
|
Interest expense
|
(3.3
|
)%
|
|
(4.3
|
)%
|
Interest and other income (expense), net
|
(3.1
|
)%
|
|
(4.0
|
)%
|
Income before income taxes
|
10.7
|
%
|
|
8.8
|
%
|
Provision for income taxes
|
7.6
|
%
|
|
6.2
|
%
|
Net income
|
3.1
|
%
|
|
2.6
|
%
|
Cost of revenue
|
0.0
|
%
|
|
0.0
|
%
|
Research and development
|
3.1
|
%
|
|
2.9
|
%
|
Sales, general and administrative
|
3.7
|
%
|
|
3.8
|
%
|
|
|
Three Months
|
|
|
|||||||
|
|
Ended March 31,
|
|
Change in
|
|||||||
(Dollars in millions)
|
|
2017
|
|
2016
|
|
Percentage
|
|||||
Total Revenue
|
|
|
|
|
|
|
|
|
|
||
Royalties
|
|
$
|
69.0
|
|
|
$
|
62.9
|
|
|
9.7
|
%
|
Contract and other revenue
|
|
28.4
|
|
|
9.8
|
|
|
189.6
|
%
|
||
Total revenue
|
|
$
|
97.4
|
|
|
$
|
72.7
|
|
|
33.9
|
%
|
|
|
Three Months Ended
|
|
|
|||||||
|
|
March 31,
|
|
Change in
|
|||||||
(Dollars in millions)
|
|
2017
|
|
2016
|
|
Percentage
|
|||||
Engineering costs
|
|
|
|
|
|
|
|
|
|
||
Cost of revenue
|
|
$
|
10.9
|
|
|
$
|
5.8
|
|
|
87.2
|
%
|
Amortization of intangible assets
|
|
8.8
|
|
|
6.4
|
|
|
38.3
|
%
|
||
Stock-based compensation
|
|
0.0
|
|
|
0.0
|
|
|
—
|
%
|
||
Total cost of revenue
|
|
19.7
|
|
|
12.2
|
|
|
61.6
|
%
|
||
Research and development
|
|
33.0
|
|
|
26.4
|
|
|
24.7
|
%
|
||
Stock-based compensation
|
|
3.0
|
|
|
2.1
|
|
|
44.8
|
%
|
||
Total research and development
|
|
36.0
|
|
|
28.5
|
|
|
26.2
|
%
|
||
Total engineering costs
|
|
$
|
55.7
|
|
|
$
|
40.7
|
|
|
36.8
|
%
|
|
|
Three Months Ended
|
|
|
|||||||
|
|
March 31,
|
|
Change in
|
|||||||
(Dollars in millions)
|
|
2017
|
|
2016
|
|
Percentage
|
|||||
Sales, general and administrative costs
|
|
|
|
|
|
|
|
|
|
||
Sales, general and administrative costs
|
|
$
|
24.6
|
|
|
$
|
20.3
|
|
|
21.1
|
%
|
Stock-based compensation
|
|
3.6
|
|
|
2.8
|
|
|
28.9
|
%
|
||
Total sales, general and administrative costs
|
|
$
|
28.2
|
|
|
$
|
23.1
|
|
|
22.0
|
%
|
|
|
Three Months Ended
|
|
|
|||||||
|
|
March 31,
|
|
Change in
|
|||||||
(Dollars in millions)
|
|
2017
|
|
2016
|
|
Percentage
|
|||||
Gain from settlement
|
|
$
|
—
|
|
|
$
|
0.4
|
|
|
(100.0
|
)%
|
|
|
Three Months
|
|
|
|||||||
|
|
Ended March 31,
|
|
Change in
|
|||||||
(Dollars in millions)
|
|
2017
|
|
2016
|
|
Percentage
|
|||||
Interest income and other income (expense), net
|
|
$
|
0.2
|
|
|
$
|
0.2
|
|
|
(36.4
|
)%
|
Interest expense
|
|
(3.2
|
)
|
|
(3.1
|
)
|
|
2.1
|
%
|
||
Interest and other income (expense), net
|
|
$
|
(3.0
|
)
|
|
$
|
(2.9
|
)
|
|
5.3
|
%
|
|
As of
|
||||||
|
March 31,
2017 |
|
December 31,
2016 |
||||
|
(In millions)
|
||||||
Cash and cash equivalents
|
$
|
177.4
|
|
|
$
|
135.3
|
|
Marketable securities
|
10.2
|
|
|
36.9
|
|
||
Total cash, cash equivalents, and marketable securities
|
$
|
187.6
|
|
|
$
|
172.2
|
|
|
Three Months Ended
|
||||||
|
March 31,
|
||||||
|
2017
|
|
2016
|
||||
|
(In millions)
|
||||||
Net cash provided by operating activities
|
$
|
17.2
|
|
|
$
|
17.8
|
|
Net cash provided by (used in) investing activities
|
$
|
25.1
|
|
|
$
|
(27.5
|
)
|
Net cash provided by (used in) financing activities
|
$
|
(0.5
|
)
|
|
$
|
2.6
|
|
|
Total
|
|
Remainder
of 2017
|
|
2018
|
|
2019
|
|
2020
|
|
2021
|
|
Thereafter
|
||||||||||||||
Contractual obligations (1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Imputed financing obligation (2)
|
$
|
20,661
|
|
|
$
|
4,743
|
|
|
$
|
6,447
|
|
|
$
|
6,602
|
|
|
$
|
2,869
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Leases and other contractual obligations
|
13,947
|
|
|
5,086
|
|
|
3,400
|
|
|
2,194
|
|
|
1,353
|
|
|
1,369
|
|
|
545
|
|
|||||||
Software licenses (3)
|
21,009
|
|
|
7,251
|
|
|
10,226
|
|
|
3,532
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||
Convertible notes
|
138,000
|
|
|
—
|
|
|
138,000
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||
Interest payments related to convertible notes
|
2,328
|
|
|
776
|
|
|
1,552
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||||
Total
|
$
|
195,945
|
|
|
$
|
17,856
|
|
|
$
|
159,625
|
|
|
$
|
12,328
|
|
|
$
|
4,222
|
|
|
$
|
1,369
|
|
|
$
|
545
|
|
(1)
|
The above table does not reflect possible payments in connection with uncertain tax benefits of approximately
$23.1 million
including
$20.7 million
recorded as a reduction of long-term deferred tax assets and
$2.4 million
in long-term income taxes payable as of
March 31, 2017
. As noted in Note 12, “Income Taxes,” of Notes to Unaudited Condensed Consolidated Financial Statements of this Form 10-Q, although it is possible that some of the unrecognized tax benefits could be settled within the next 12 months, we cannot reasonably estimate the outcome at this time.
|
(2)
|
With respect to the imputed financing obligation, the main components of the difference between the amount reflected in the contractual obligations table and the amount reflected on the unaudited condensed consolidated balance sheets are the interest on the imputed financing obligation and the estimated common area expenses over the future periods. The amount includes the amended Ohio lease and the amended Sunnyvale lease.
|
(3)
|
We have commitments with various software vendors for non-cancellable agreements generally having terms longer than
one
year.
|
•
|
expenditure of significant financial and research and development resources in efforts to analyze, correct, eliminate or work around breaches, errors, bugs or defects or to address and eliminate vulnerabilities;
|
•
|
financial liability to customers for breach of certain contract provisions, including indemnification obligations;
|
•
|
loss of existing or potential customers;
|
•
|
delayed or lost revenue;
|
•
|
delay or failure to attain market acceptance;
|
•
|
negative publicity, which would harm our reputation; and
|
•
|
litigation, regulatory inquiries or investigations that would be costly and harm our reputation.
|
•
|
hiring, maintaining and managing a workforce and facilities remotely and under various legal systems, including compliance with local labor and employment laws;
|
•
|
non-compliance with our code of conduct or other corporate policies;
|
•
|
natural disasters, acts of war, terrorism, widespread illness or security breaches;
|
•
|
export controls, tariffs, import and licensing restrictions and other trade barriers;
|
•
|
profits, if any, earned abroad being subject to local tax laws and not being repatriated to the United States or, if repatriation is possible, limited in amount;
|
•
|
adverse tax treatment of revenue from international sources and changes to tax codes, including being subject to foreign tax laws and being liable for paying withholding, income or other taxes in foreign jurisdictions;
|
•
|
unanticipated changes in foreign government laws and regulations;
|
•
|
increased financial accounting and reporting burdens and complexities;
|
•
|
lack of protection of our intellectual property and other contract rights by jurisdictions in which we may do business to the same extent as the laws of the United States;
|
•
|
potential vulnerability to computer system, internet or other systemic attacks, such as denial of service, viruses or other malware which may be caused by criminals, terrorists or other sophisticated organizations;
|
•
|
social, political and economic instability;
|
•
|
geopolitical issues, including changes in diplomatic and trade relationships; and
|
•
|
cultural differences in the conduct of business both with customers and in conducting business in our international facilities and international sales offices.
|
•
|
any progress, or lack of progress, real or perceived, in the development of products that incorporate our innovations and technology companies' acceptance of our products, including the results of our efforts to expand into new target markets;
|
•
|
our signing or not signing new licenses and the loss of strategic relationships with any customer;
|
•
|
announcements of technological innovations or new products by us, our customers or our competitors;
|
•
|
changes in our strategies, including changes in our licensing focus and/or acquisitions of companies with business models or target markets different from our own;
|
•
|
positive or negative reports by securities analysts as to our expected financial results and business developments;
|
•
|
developments with respect to patents or proprietary rights and other events or factors;
|
•
|
new litigation and the unpredictability of litigation results or settlements; and
|
•
|
issuance of additional securities by us, including in acquisitions.
|
•
|
we may be more vulnerable to economic downturns, less able to withstand competitive pressures and less flexible in responding to changing business and economic conditions;
|
•
|
our ability to obtain additional financing in the future for working capital, capital expenditures, acquisitions, litigation, general corporate or other purposes may be limited;
|
•
|
a substantial portion of our cash flows from operations in the future may be required for the payment of the principal amount of our existing indebtedness when it becomes due at maturity in August 2018; and
|
•
|
we may be required to make cash payments upon any conversion of the 2018 Notes, which would reduce our cash on hand.
|
•
|
our board of directors is authorized, without prior stockholder approval, to create and issue preferred stock, commonly referred to as “blank check” preferred stock, with rights senior to those of common stock, which means that a stockholder rights plan could be implemented by our board;
|
•
|
our board of directors is staggered into two classes, only one of which is elected at each annual meeting;
|
•
|
stockholder action by written consent is prohibited;
|
•
|
nominations for election to our board of directors and the submission of matters to be acted upon by stockholders at a meeting are subject to advance notice requirements;
|
•
|
certain provisions in our bylaws and certificate of incorporation such as notice to stockholders, the ability to call a stockholder meeting, advance notice requirements and action of stockholders by written consent may only be amended with the approval of stockholders holding 66 2/3% of our outstanding voting stock;
|
•
|
our stockholders have no authority to call special meetings of stockholders; and
|
•
|
our board of directors is expressly authorized to make, alter or repeal our bylaws.
|
•
|
any current or future U.S. or foreign patent applications will be approved and not be challenged by third parties;
|
•
|
our issued patents will protect our intellectual property and not be challenged by third parties;
|
•
|
the validity of our patents will be upheld;
|
•
|
our patents will not be declared unenforceable;
|
•
|
the patents of others will not have an adverse effect on our ability to do business;
|
•
|
Congress or the U.S. courts or foreign countries will not change the nature or scope of rights afforded patents or patent owners or alter in an adverse way the process for seeking or enforcing patents;
|
•
|
changes in law will not be implemented, or changes in interpretation of such laws will occur, that will affect our ability to protect and enforce our patents and other intellectual property;
|
•
|
new legal theories and strategies utilized by our competitors will not be successful;
|
•
|
others will not independently develop similar or competing chip interfaces or design around any patents that may be issued to us; or
|
•
|
factors such as difficulty in obtaining cooperation from inventors, pre-existing challenges or litigation, or license or other contract issues will not present additional challenges in securing protection with respect to patents and other intellectual property that we acquire.
|
|
RAMBUS INC.
|
|
|
|
|
Date: April 28, 2017
|
By:
|
/s/ Rahul Mathur
|
|
|
Rahul Mathur
|
|
|
Senior Vice President, Finance and Chief Financial Officer
|
|
|
(Principal Financial Officer and Duly Authorized Officer)
|
|
|
|
|
|
|
Exhibit
Number
|
|
Description of Document
|
|
|
|
31.1
|
|
Certification of Principal Executive Officer, pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
31.2
|
|
Certification of Principal Financial Officer, pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
32.1*
|
|
Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
32.2*
|
|
Certification of Principal Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
101.INS
|
|
XBRL Instance Document
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
*
|
The certifications furnished in Exhibit 32.1 and 32.2 hereto are deemed to accompany this Quarterly Report on Form 10-Q and will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended. Such certifications will not be deemed to be incorporated by reference into any filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except to the extent that the registrant specifically incorporates it by reference.
|
1 Year Rambus Chart |
1 Month Rambus Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions